RELATED PARTY TRANSACTIONS (Tables)

9 Months Ended

Dec. 31, 2018

Related Party Transactions Tables Abstract

Schedule of Related Party Transactions

Following is a summary of activity between the Company and Pharma and NDM for the nine months ended December 31, 2018 and 2017. These amounts are unsecured, interest free, and payable on demand.

	Three Months Ended December 31, 2018 (unaudited) ($)			Three Months Ended December 31, 2017 (unaudited) ($)			Nine Months Ended December 31, 2018 (unaudited) ($)			Nine Months Ended December 31, 2017 (unaudited) ($)			Year Ended March 31, 2018 ($)
Balance due from (to) Pharma and NDM at beginning of period		(642,513	)		(507,376	)		(613,818	)		(687,609	)		(687,609	)
Amounts invoiced by Pharma to DDL, NM and TCL (1)		(389,329	)		(314,706	)		(1,539,114	)		(554,464	)		(842,739	)
Amounts repaid by DDL to Pharma		92,025			-			1,130,755			440,266			1,096,767
Amounts paid by DDL on behalf of Pharma		-			-			-			19,889			19,889
Amounts received from Pharma		-			-			-			-			(145,214	)
Foreign exchange differences		21,023			(4,228	)		103,383			(44,392	)		(54,912	)
Balance due to Pharma and NDM at end of the period		(918,794	)		(826,310	)		(918,794	)		(826,310	)		(613,818	)

(1) These amounts are included primarily in research and development expenses charged to the Company by Pharma.